0
Business update: AstraZeneca rejects sweetened Pfizer takeover bid

Pharmaceutical company AstraZeneca on Friday flatly rejected drug maker Pfizer’s sweetened takeover bid — worth $106 billion — just hours after it was levelled, describing it as inadequate.

Leave a Reply

Your email address will not be published. Required fields are marked *